Aldeyra therapeutics selected to present at the disruptive innovations symposium during the osn new york retina 2024 meeting

Lexington, mass.--(business wire)--aldeyra therapeutics, inc. (nasdaq: aldx) (aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that tomasz stryjewski, m.d., chief medical advisor - retina, will present at the disruptive innovations symposium during the ocular surgery news (osn) new york retina 2024 meeting, which takes place in new york, new york november 8-10, 2024. dr. stryjew.
OSN Ratings Summary
OSN Quant Ranking